Envoy Medical, Inc. (NASDAQ:COCH) Sees Significant Drop in Short Interest

Envoy Medical, Inc. (NASDAQ:COCH) was the recipient of a significant drop in short interest during the month of October. As of October 30th, there was short interest totaling 89,915 shares, a drop of 84.4% from the October 15th total of 577,087 shares. Based on an average daily volume of 33,639 shares, the short-interest ratio is currently 2.7 days. Approximately 1.3% of the company’s shares are short sold.

Latest Envoy Medical News

These are some of the COCH news items that stood out recently:

• Positive Sentiment: HC Wainwright raised its FY2026 EPS estimate to a loss of $2.61 per share from a projected loss of $3.10, while keeping its Buy rating and $18 price target. HC Wainwright Reaffirms Buy Rating for Envoy Medical
• Positive Sentiment: Reported short interest fell 84.4% in October, to 89,915 shares, reducing the amount of bearish positioning in the stock. Envoy Medical Shares Shorted: Short Interest Down 84.4% in October
• Neutral Sentiment: A separate report said short interest was zero as of November 10, which conflicts with the October figure; the discrepancy makes the latest short-interest picture uncertain.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $18.00 target price on shares of Envoy Medical in a research note on Monday. Loop Capital set a $20.00 price target on shares of Envoy Medical in a research report on Monday, July 27th. Lake Street Capital raised their price target on shares of Envoy Medical from $2.50 to $25.00 and gave the stock a “buy” rating in a report on Tuesday, October 27th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Envoy Medical in a research report on Monday, October 19th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $21.00.

Envoy Medical Stock Performance

Shares of Envoy Medical stock traded down $0.14 during midday trading on Thursday, reaching $6.81. 12,917 shares of the company’s stock traded hands, compared to its average volume of 39,270. The company has a market cap of $52.57 million, a PE ratio of -1.48 and a beta of 2.03. The stock has a 50 day moving average of $6.81 and a 200-day moving average of $6.88. Envoy Medical has a 12 month low of $3.63 and a 12 month high of $9.54.

Envoy Medical (NASDAQ:COCH) last released its quarterly earnings results on Thursday, November 5th. The company reported ($0.50) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.17. The company had revenue of $0.07 million during the quarter, compared to the consensus estimate of $0.09 million. Envoy Medical had a negative net margin of 9,026.41% and a negative return on equity of 5,250.23%. On average, equities analysts anticipate that Envoy Medical will post -2.61 earnings per share for the current fiscal year.

About Envoy Medical

Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with sensorineural hearing loss. Unlike conventional hearing aids and many cochlear implants, its technology is designed to be placed beneath the skin, with no external wearable sound processor. The company’s lead product is the Acclaim Cochlear Implant, a fully implanted cochlear implant intended to address moderate-to-profound sensorineural hearing loss in adults. The system is designed to use the body’s natural anatomy to capture sound and convert it into electrical signals that stimulate the auditory nerve.